DEEP LEARNING
Understanding spatial biology to unravel personalized medicine: Multiplex Immunofluorescence IHC combined to Deep Learning is leading the way
By Charlotte Plestant, Louis Jeay, Suliman Bouizaguen, David Guet -
26 Jul 2021
Delivering the right treatment to the right patient, and at the right time. This motto has become the driving force in drug development, placing solutions empowering personalized medicine as a top priority in the Pathology field. The scientific community is striving to answer the technological needs required by such a challenge. Multiplex fluorescence IHC (immunohistochemistry) is a revolutionary method offering powerful possibilities in simultaneous analysis of multiple biomarkers on whole tissue sections. In this post, we describe why understanding spatial biology, the study of tissues in their 2D and 3D context, is the next big step the field has to take and how Deep Learning will assist in unraveling personalized medicine.